Clinical Trials Browser

Phase 1/2 × NETWORK × Plasma cell × Clear all

NCT03732703 2025-02-14

MyDRUG

Phase 1/2 Completed

Multiple Myeloma

NCT04150965 2025-02-14

Immuno-Oncology Drugs Elotuzumab, Anti-LAG-3 and Anti-TIGIT

Phase 1/2 Terminated

Multiple Myeloma, Recurrence

NCT02204241 2023-07-03

CCD

Phase 1/2 Completed

Disease, Multiple Myeloma

NCT01460420 2017-07-06

EMN-alloRIC

Phase 1/2 Completed

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms